vimarsana.com
Home
Live Updates
Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Pr
Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Pr
Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications
– New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment by enabling performance of the TLR9 agonist, SD-101, in metastatic uveal...
Related Keywords
Texas ,
United States ,
Stevenc Katz ,
Trisalu Trinav ,
Sapna Patel ,
Twitter ,
Exchange Commission ,
University Of Texas Md Anderson Cancer Center ,
Trisalus Life Sciences ,
Nasdaq ,
Linkedin ,
Society Of Immunotherapy ,
Trisalus Life ,
Infusion System ,
Progression Free Survival ,
Disease Control Rate ,
Chief Medical Officer ,
Pressure Enabled Regional Immuno Oncology ,
Pressure Enabled Drug Delivery ,
Pancreatic Retrograde Venous Infusion System ,
Private Securities Litigation Reform Act ,
Markets ,